[Effects of selective induceble nitric oxide synthase inhibitor on immunological hepatic injury in rat]

G Zhang1, Z Lin, B Zhang

  • 1Department of Pharmacology, Beijing Medical University.

Zhonghua Yi Xue Za Zhi
|August 3, 2000
PubMed
Abstract

Insights

Nitric oxide (NO) produced during immunological stimuli contributes to rat liver injury. An inducible nitric oxide synthase (iNOS) inhibitor reduced NO production and liver damage markers.

Area of Science:

  • Immunology
  • Hepatology
  • Biochemistry

Background:

  • Immunological hepatic injury is a complex process.
  • The role of nitric oxide (NO) in this injury is not fully understood.
  • Investigating the regulation of inducible nitric oxide synthase (iNOS) is crucial.

Purpose of the Study:

  • To explore the function and regulation of NO in rat immunological hepatic injury.
  • To assess the impact of a selective iNOS inhibitor on this process.

Main Methods:

  • In situ PCR was used to determine intracellular NOS gene expression in immune-damaged hepatocytes.
  • NO concentration and lactate dehydrogenase (LDH) activity were measured in culture supernatants.
  • The effects of bacille calmette guerin (BCG) and inflammatory cytokines were evaluated.

Main Results:

  • BCG administration, alone or with inflammatory cytokines, significantly increased NO production and LDH release (P < 0.05).
  • Hepatocytes primarily expressed iNOS mRNA under immunological stimuli.
  • Aminoguanidine (AG), an iNOS inhibitor, reduced NO production and LDH release, while actinomycin D enhanced LDH levels.

Conclusions:

  • NO generated by immunological stimuli plays a role in the mechanism of rat hepatic injury.
  • Targeting iNOS may offer a therapeutic strategy for immunological liver damage.

Related Concept Videos